Company facts
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Fremont, California
- Most recent report
- 8-K, filed Sep 1, 2026
- Incorporated
- Delaware
- Filings on record
- 48 filings
- On EDGAR
- CIK 2104204
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 2
News 5
Prospectuses and Registrations 6
- S-8 Registration statement for an employee plan Apr 20, 2026
- POS AM Post-effective amendment to a registration Apr 20, 2026
- 424B4 Final prospectus for an offering Apr 17, 2026
- S-1/A Registration statement for an offering, amended Apr 16, 2026
- S-1/A Registration statement for an offering, amended Apr 13, 2026
- S-1 Registration statement for an offering Mar 27, 2026
Ownership 8 of 27
- 4 Insider reported a trade Sep 3, 2026
- 3 Insider reported their initial holding Sep 3, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 11, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 2, 2026
- SCHEDULE 13D Large holder reported an active stake Apr 23, 2026
- SCHEDULE 13D Large holder reported an active stake Apr 23, 2026
Other 8
- EFFECT Notice that a registration became effective Apr 20, 2026
- EFFECT Notice that a registration became effective Apr 16, 2026
- S-1MEF Apr 16, 2026
- CERT Exchange certified a listing Apr 16, 2026
- 8-A12B Registration of a security for exchange listing Apr 15, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Mar 12, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Feb 17, 2026
- DRS Draft registration statement, submitted confidentially Jan 9, 2026
Everything here comes from Alamar Biosciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.